Ads
related to: liver disease testhealthlabs.com has been visited by 10K+ users in the past month
A+ Rating - Better Business Bureau
- Find A Lab Near You
Over 4,000 Labs Nationwide For Your
Convenience, No Doctor Order Needed
- Payment Options
Self Pay Testing - No Insurance
All Credit Cards Accepted
- Find A Lab Near You
renewyourliver.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Liver function tests (LFTs or LFs), also referred to as a hepatic panel or liver panel, are groups of blood tests that provide information about the state of a patient's liver. [1] These tests include prothrombin time (PT/INR), activated partial thromboplastin time (aPTT), albumin , bilirubin (direct and indirect), and others.
Diagnosing Fatty Liver Disease. Fatty liver disease can be easy to miss, as many people don’t experience symptoms. If you get a liver function test for another reason, your healthcare provider ...
Liver disease; Other names: Hepatic disease: A gross pathology specimen of liver metastases caused by pancreatic cancer: Specialty: Hepatology, gastroenterology: Types: Fatty liver disease, Hepatitis (and several more) [1] Diagnostic method: Liver function tests [2] Treatment: Depends on type(See types)
FibroTest has been evaluated in relation to liver biopsy (the current reference standard in liver disease assessment) in people with hepatitis C, hepatitis B, [1] alcoholic liver disease, [2] and non-alcoholic fatty liver disease. [3] They are most useful for cirrhosis and less useful for other stages of liver disease. [4]
Hepascore is a blood test developed in Australia combining the following clinical and laboratory variables: age, gender, bilirubin, GGT, hyaluronic acid, alpha 2 macroglobin to create a score. The test has been validated for patients with hepatitis B, [24] hepatitis C [25] and non-alcoholic fatty liver disease. [26]
The Model for End-Stage Liver Disease, or MELD, is a scoring system for assessing the severity of chronic liver disease.It was initially developed to predict mortality within three months of surgery in patients who had undergone a transjugular intrahepatic portosystemic shunt (TIPS) procedure, [1] and was subsequently found to be useful in determining prognosis and prioritizing for receipt of ...
Ads
related to: liver disease testhealthlabs.com has been visited by 10K+ users in the past month
A+ Rating - Better Business Bureau
renewyourliver.com has been visited by 10K+ users in the past month